Home › Atopic Dermatitis (Eczema) › North Carolina
Atopic Dermatitis (Eczema) clinical trials in North Carolina
8 studies for Atopic Dermatitis (Eczema) are looking for participants at sites in North Carolina.
Cities in North Carolina
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
- Piedmont Plastic Surgery and Dermatology- Site Number : 8400038, Huntersville
- Wake Forest University Health Sciences- Site Number : 8400003, Winston-Salem
RecruitingObservational study
Ages 12 and older · All sexes · Updated Sep 29, 2026 · NCT07290803Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
- Enveda Investigative Site, Wilmington
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 25, 2026 · NCT07298395A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
- Investigational Site, Wilmington
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT07003425A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
- Inmagene Site 20, Charlotte
RecruitingPhase 2
Ages 18 to 74 · All sexes · Updated Aug 12, 2026 · NCT07037901Topical Treatment for Atopic Dermatitis
- Wake Forest University Health Sciences, Winston-Salem
Recruiting
Ages 9 and older · All sexes · Updated Aug 4, 2026 · NCT06244212A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
- Piedmont Plastic Surgery and Dermatology - Huntersville /ID# 266545, Huntersville
RecruitingPhase 3
Ages 18 to 63 · All sexes · Updated Jul 6, 2026 · NCT06389136An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis Exposed to Ruxolitinib Cream Versus Topical Corticosteroids During Pregnancy: A US Claims Database Analysis
- Syneos Health (remote site), Morrisville
RecruitingObservational study
Ages 14 and older · Women · Updated Dec 11, 2025 · NCT06627335Study to Compare Maternal, Fetal, and Infant Outcomes of Women With Mild to Moderate Atopic Dermatitis Exposed to Ruxolitinib Cream During Pregnancy With an Unexposed Control Population
- Syneos Health (remote site), Morrisville
RecruitingObservational study
Ages 15 to 50 · Women · Updated Dec 11, 2025 · NCT06259669From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.